PROCTER & GAMBLE HEALTH
|
The Current P/S Ratio of PROCTER & GAMBLE HEALTH is 6.34.
| Share Price | ₹5,691.7 | Nov 09,2026 |
| Market Cap | ₹9,448.1 Cr | |
| Sales-TTM | ₹1,490.5 Cr | TTM-Standalone Results |
| Price/Sales | 6.34x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of PROCTER & GAMBLE HEALTH
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹9,448.1 Cr] as on Nov 09,2026
(/) Sales [ ₹1,490.5 Cr] based on TTM-Standalone Results
(=) P/S Ratio [ 6.34x ]
Thus, for PROCTER & GAMBLE HEALTH , the investors are currently willing to pay '6.34 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of PROCTER & GAMBLE HEALTH !
The chart below summarizes the trend in P/S Ratio of PROCTER & GAMBLE HEALTH over the last five years.
Historical PS (Price/Sales) ratio chart of PROCTER & GAMBLE HEALTH
PS Ratio Performance Analysis for PROCTER & GAMBLE HEALTH
- PROCTER & GAMBLE HEALTH 's p/e ratio for fiscal years ending Mar2026 to Jun2022 averaged 7.08x.
- PROCTER & GAMBLE HEALTH 's operated at median p/e ratio of 7.09x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, PROCTER & GAMBLE HEALTH 's p/e ratio peaked in Mar2025 at 9.14x.
- PROCTER & GAMBLE HEALTH 's p/e ratio hit its five-year low in Mar2026 of 5.66x.
How does PROCTER & GAMBLE HEALTH 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| PROCTER & GAMBLE HEALTH | 1,490.5 | 6.34 | 9,448.1 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 61,630.9 | 7.42 | 457,073.0 |
| DIVIS LABORATORIES LTD | 12,191.0 | 25.19 | 307,147.0 |
| TORRENT PHARMACEUTICALS LTD | 17,400.0 | 10.44 | 181,626.0 |
| CIPLA LTD | 28,138.9 | 4.04 | 113,589.0 |
| DR REDDYS LABORATORIES LTD | 33,097.4 | 3.50 | 115,685.0 |
| MANKIND PHARMA LTD | 15,378.6 | 7.15 | 109,911.0 |
| LUPIN LTD | 30,746.3 | 2.99 | 92,007.4 |
| ZYDUS LIFESCIENCES LTD | 30,378.1 | 3.98 | 121,002.0 |
| AUROBINDO PHARMA LTD | 36,912.9 | 2.88 | 106,445.0 |
| LAURUS LABS LTD | 7,822.5 | 16.92 | 132,376.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs PROCTER & GAMBLE HEALTH 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.88x |
| Max industry PS | 25.19x |
| Median industry PS | 6.34x |
| Average industry PS | 8.26x |
You may also like the below Video Courses